Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2019

Planlagt Fastgjort Låst Flyttet Genmab
2.8k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #950

    Det trækker kursen op. Der er ikke mange som er villige til at sælge.

    1 Reply Last reply
    0
    • J Offline
      J Offline
      Joakim_Von_And
      wrote on sidst redigeret af
      #951

      Der må være noget på vej med den stigning.

      1 Reply Last reply
      0
      • P Offline
        P Offline
        peter12
        wrote on sidst redigeret af
        #952

        ER der nogen der kender Melflufen https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=9&cad=rja&uact=8&ved=2ahUKEwib2PWByfTfAhXJDywKHeDtDkYQFjAIegQIBBAC&url=https%3A%2F%2Fwww.oncopeptides.se%2Fen%2Fwp-content%2Fuploads%2Fsites%2F2%2F2019%2F01%2Foncopeptides-jpm-2019-3.pdf ? Kan se at der køre forsøg med dara ...

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #953

          https://www.ashclinicalnews.org/on-lo cation/good-news-horizon-melflufen-induces-response-heavily-refractory-myeloma/ https://netdoktor.dk/medicin/skema/cytostatika.htm

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #954

            prøver igen https://www.ashclinicalnews.org/on-location/good-news-horizon-melflufen-induces-response-heavily-refractory-myeloma/

            1 Reply Last reply
            0
            • P Offline
              P Offline
              peter12
              wrote on sidst redigeret af
              #955

              De kunne da hurtig blive spist 😉

              1 Reply Last reply
              0
              • K Offline
                K Offline
                kkjoel
                wrote on sidst redigeret af
                #956

                Sukkeralf (eller andre der har faglig viden omkring dette:), fra ADC Therapeutics hjemmeside, som du så venligt linkede til i går (om ADCT-301 interim data på 113 HL patienter i ph Ia/Ib):
                "In HL patients with a median of five prior lines of therapy and no other approved therapy options, the overall response rate was 86.5 percent, including a 43 percent compl
                ete response rate,.."

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  kkjoel
                  wrote on sidst redigeret af
                  #957

                  Som lægmand drister jeg mig til at spørge: Er dette ikke vildt imponerende tal i 6. linje.. det er vel ikke normalt at man kan få en så høj responsrate (specielt CR - kræft ikke målbar længere - på næsten halvdelen) hos patienter, der har prøvet så mange andre behandlinger
                  først?

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    kkjoel
                    wrote on sidst redigeret af
                    #958

                    Og hvordan ville man have stillet sig, hvis tallene havde været 1. linje.. det ville være så fedt hvis du kunne sige lidt generelt (vedr. kræft bredt og/eller specifikt HL/MM) omkring sammenhængen mellem muligheden for "dyb" respons og hvilken linje man behandler?

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      kkjoel
                      wrote on sidst redigeret af
                      #959

                      Og skal minde om at GEN ejer 25% af rettighederne.. så GO ADCT!

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #960

                        Det lyder som et meget potent stof 😉 Og desværre mange patienter

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          kkjoel
                          wrote on sidst redigeret af
                          #961

                          Her linket til ADC Therapeutics igen https://adctherapeutics.com/

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #962

                            @Bulder if you are interested in Melflufen , i read this presentation earlier https://www.oncopeptides.se/en/2019-j-p-morgan-health-care-conference-presentation/

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #963

                              @kkjoel i imagine @Sukkeralf posted that link for the news on ADCT-601 , which they develop alone if i am correct

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #964

                                based 301 data at ASH18 they plan a PhII trial in 2019

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  kkjoel
                                  wrote on sidst redigeret af
                                  #965

                                  Yes, you're probably right. But GEN only has part in ADCT-301, so that's why I focused that direction..

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    kkjoel
                                    wrote on sidst redigeret af
                                    #966

                                    Have you got any thoughts on response rates on a late 6. line? (It was probably discussed here after ASH.) And any insights into correlation between possibility for "deep" response and how far down treament-regime one is? (maybe also that was discussed here after ASH..)

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      kkjoel
                                      wrote on sidst redigeret af
                                      #967

                                      Ahhhh, ADCT-601 binder til AXL.. så osse derfor specifkt interessant i GEN regi (enapotamab vedotin)

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #968

                                        Så eftersom begge stoffer binder til AXL, ligner det derfor spørgsmålet om det er ADCTs eller GENs cellegift der er den bedste/kan fåes til at virke bedst?

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #969

                                          Hvor ADCT har deres egen gift, mens GENs kommer fra Seatlle Genetics.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger